Clin. Vaccine Immunol.
doi:10.1128/CVI.00090-08
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.
Influenza vaccination induces interleukin-12/23 receptor beta1-independent production of interferon-gamma: cellular and humoral immune response to influenza vaccine in patients with genetic deficiency in interleukin-12/23 receptor-
1 or interferon-gamma receptor-1
Tjitske de Boer,
Jaap T. van Dissel,
Taco W. J. Kuijpers,
Guus F. Rimmelzwaan,
Frank P. Kroon,
and
Tom H.M. Ottenhoff*
Department of Infectious Diseases, LUMC, Leiden, the Netherlands; Emma Children's Hospital at the Academic Medical Center (AMC), Amsterdam, the Netherlands; Department of Virology, EUR, Rotterdam, the Netherlands
* To whom correspondence should be addressed. Email:
t.h.m.ottenhoff{at}lumc.nl.
 |
Abstract |
|---|
To investigate whether protective immune responses can be induced in the absence of normal IL-12/23/IFN-
-axis signalling, we vaccinated two patients with complete IL-12/23R
1-deficiency, two patients with partial IFN-
RI deficiency, and five healthy controls with the seasonal influenza subunit vaccine. Blood samples were analysed before, and 7 and 28 days after vaccination. In most cases antibody titers reached protective levels. Moreover, although T-cell responses in patients were lower than those observed in controls, significant influenza-specific T-cell proliferation, IFN-
production, and numbers of IFN-
producing cells were found in all patients 7 days after the vaccination. Interestingly, influenza-specific IFN-
responses were IL-12/23 independent, in striking contrast to mycobacterium-induced IFN-
production. In conclusion, influenza vaccination induces IL-12/23-independent IFN-
production by T-cells, and can result in sufficient humoral protection in both IL-12/23R
1- and pIFN-
RI-deficient individuals.